Aclarion, Inc. Common Stock (ACON)

Price$3.57

Growth ScoreB

Momentum ScoreC

Favorite Metrics

Price vs S&P 500 (26W)-50.90%

Price vs S&P 500 (4W)12.10%

VGM Score57.10

Market Capitalization$8.79M

All Metrics

Book Value / Share (Quarterly)$8.04

P/TBV (Annual)4.47x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)7.83%

Cash Flow / Share (Quarterly)$-3.06

Price vs S&P 500 (YTD)-30.55%

Gross Margin (TTM)19.34%

Net Profit Margin (TTM)-10336.12%

EPS (TTM)$-9.56

10-Day Avg Trading Volume0.14M

EPS Excl Extra (TTM)$-9.56

Revenue Growth (5Y)9.28%

EPS (Annual)$-13.60

ROI (Annual)-720.92%

Gross Margin (Annual)9.02%

Net Profit Margin (5Y Avg)-10254.64%

Cash / Share (Quarterly)$7.77

Revenue Growth QoQ (YoY)11.32%

ROA (Last FY)-329.86%

Revenue Growth TTM (YoY)42.56%

EBITD / Share (TTM)$-8.23

Operating Margin (TTM)-10975.27%

Cash Flow / Share (Annual)$-4.56

P/B Ratio0.45x

P/B Ratio (Quarterly)0.38x

Net Income / Employee (Annual)$-657,600

EV / Revenue (TTM)-131.16x

Net Interest Coverage (TTM)-12.07x

ROA (TTM)-51.71%

EPS Incl Extra (Annual)$-13.60

Current Ratio (Annual)0.71x

Quick Ratio (Quarterly)19.35x

3-Month Avg Trading Volume0.10M

52-Week Price Return-47.14%

Revenue / Employee (TTM)$7,100

Tangible BV / Share (Quarterly)$7.53

P/S Ratio (Annual)116.07x

Asset Turnover (Annual)0.02x

52-Week High$12.03

Operating Margin (5Y Avg)-8982.77%

EPS Excl Extra (Annual)$-13.60

CapEx CAGR (5Y)2.64%

26-Week Price Return-42.97%

Quick Ratio (Annual)0.56x

13-Week Price Return16.67%

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)19.65x

Enterprise Value$-10.21M

Revenue / Share Growth (5Y)7.44%

Asset Turnover (TTM)0.01x

Revenue / Employee (Annual)$6,900

Pretax Margin (Annual)-9551.87%

Cash / Share (Annual)$1.30

3-Month Return Std Dev59.03%

Gross Margin (5Y Avg)-19.88%

Net Income / Employee (TTM)$-731,800

ROE (Last FY)-720.92%

Net Interest Coverage (Annual)-31.92x

EPS Basic Excl Extra (Annual)$-13.60

Receivables Turnover (TTM)2.61x

Total Debt / Equity (Quarterly)0.00x

EPS Incl Extra (TTM)$-9.56

Receivables Turnover (Annual)4.73x

ROI (TTM)-54.41%

P/S Ratio (TTM)112.87x

Pretax Margin (5Y Avg)-10254.64%

Revenue / Share (Annual)$0.14

Tangible BV / Share (Annual)$2.07

Price vs S&P 500 (52W)-71.51%

Year-to-Date Return-22.39%

5-Day Price Return5.93%

EPS Normalized (Annual)$-13.60

ROA (5Y Avg)-278.57%

Net Profit Margin (Annual)-9551.87%

Month-to-Date Return8.84%

Cash Flow / Share (TTM)$-0.52

EBITD / Share (Annual)$-13.95

Operating Margin (Annual)-10103.97%

EPS Basic Excl Extra (TTM)$-9.56

P/TBV (Quarterly)0.41x

P/B Ratio (Annual)1.55x

Pretax Margin (TTM)-10336.12%

Book Value / Share (Annual)$4.53

Price vs S&P 500 (13W)8.41%

Beta1.17x

Revenue / Share (TTM)$0.04

ROE (TTM)-54.41%

52-Week Low$2.34

gGradeB

mGradeC

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-1.34est. -1.58

Analyst Recommendations

Mar 2026

Apr 2026

May 2026

Jun 2026

4.14

Industry Peers — Health Services(28)

Symbol	Value Score	Growth Score	Momentum Score	Price
ACONAclarion, Inc. Common Stock	—	B	C	$3.57
NTRANatera, Inc. Common Stock	F	A	C	$215.31
DGXQuest Diagnostics Inc.	C	D	C	$200.29
LHLabcorp Holdings Inc.	C	D	C	$265.15
EXASExact Sciences Corp	F	B	B	$0.00
GHGuardant Health, Inc. Common Stock	F	A	B	$125.61
CAICaris Life Sciences, Inc. Common Stock	F	A	D	$16.49
CELCCelcuity Inc. Common Stock	—	—	C	$88.28
RDNTRadNet, Inc. Common Stock	D	C	C	$54.34
VCYTVeracyte, Inc.	D	A	B	$48.73
GRALGRAIL, Inc. Common Stock	D	A	C	$59.98

About

Aclarion Inc provides Nociscan, a SaaS diagnostic platform that uses proprietary Magnetic Resonance Spectroscopy technology to help physicians noninvasively identify painful spinal discs. The company generates revenue by delivering diagnostic reports to medical professionals in the United States.